Dr Lisa Wilde, Director of Research, Policy and Influencing, shares her reflections from the Global Early-Onset Colorectal Cancer Think Tank (GEOCRCTT) in Barcelona.

We’re excited to invite North East Lincolnshire locals to walk inside a giant inflatable bowel to raise awareness of bowel cancer and its symptoms.

A credit card sized leaflet summarising the facts about bowel cancer. This explains what symptoms to look out for and how to reduce your risk. This pocket sized leaflet is ideal for awareness-raising ...

The results of the Cancer Prevention Project 3 (CaPP3) trial, a study changing how we think about aspirin and cancer prevention for people with Lynch syndrome.

In 2023 we launched our bold new five-year strategy 'On a Mission', we knew it was ambitious, but achievable. Today we’ve published our Annual Report and Accounts 2024, and it’s clear the year marks a ...

The Government has published its 10 Year Health Plan, following a consultation to shape the future of the NHS in England.

NICE has approved the use of the drug fruquintinib (Fruzaqla) for eligible advanced bowel cancer patients living in England and Wales.

We’re campaigning to improve the diagnosis and care of people with Lynch syndrome. As part of this work, we bought together academics, clinicians, and policymakers for a roundtable discussion to make ...

Read more about our current projects partnering with leading clinicians, institutions and academics across the UK.

If tests show cancer cells in your colon or rectum, you will need more tests to stage the cancer. You may have a CT, MRI, ultrasound, or PET-CT scan.

Take on the iconic National Three Peaks Challenge and tackle the three highest mountains in the UK with #TeamBowelCancerUK.

We’re the UK’s leading bowel cancer charity. We’re determined to save lives and improve the quality of life of everyone affected by bowel cancer.